Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2014 by Brown University.
Recruitment status was  Active, not recruiting
Yale University
Information provided by (Responsible Party):
William Sikov, Brown University Identifier:
First received: February 6, 2008
Last updated: July 15, 2014
Last verified: July 2014
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2014
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):